Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party (HCPWP) joint meeting - Workshop on the patient's voice in the evaluation of medicines

• Date:
  donderdag, 26 september 2013, Hele dag
• Locatie:
  European Medicines Agency, Amsterdam, the Netherlands

Representatives from patients', consumers' and healthcare professionals' organisations, together with the European Federation of Pharmaceutical Industries and Associations, and Committee for Medicinal Products for Human Use and Pharmacovigilance Risk Assessment Committee representatives, are meeting to discuss the different ways of involving patients in benefit / risk assessments, from the early stages of development of a medical product, through to its authorisation and beyond. Registration by invitation only.

Documents

Agenda - Workshop on the patient’s voice in the evaluation of medicines

Reference Number: EMA/437597/2013

List of participants - Workshop on the patient’s voice in the evaluation of medicines

Reference Number: EMA/489088/2013

Report - Workshop on the patient’s voice in the evaluation of medicines

Reference Number: EMA/607864/2013

Presentation - Workshop on patient’s voice in the evaluation of medicines - Objective and introduction (Isabelle Moulon)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Introduction (June M Raine)

Presentation - Workshop on patient’s voice in the evaluation of medicines - The impatient patient - From anger to activism (EATG)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Values and Preferences for Treatment Outcomes: the MACBETH Approach (Andrea Beyer)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Study design (Andrea Beyer)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Patient input into benefit/risk issues during drug development(EFPIA)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Scientific advice/protocol assistance and patient representatives (Kristina Larsson)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Benefit/Risk survey (M Mavris)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Patient input into benefit/risk issues during evaluation (EFPIA)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Scientific Advisory Groups (Francesco Pignatti)

Presentation - Workshop on patient’s voice in the evaluation of medicines - CPMP / CHMP consultations with patients on benefits/risks(Franà§ois Houà¿ez)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Patient involvement in the CHMP (Patrick Salmon)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Patient involvement in the PRAC (Albert van der Zeijden)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Patient involvement in the PRAC (Jane Ahlqvist Rastad)

Presentation - Workshop on patient’s voice in the evaluation of medicines - Incorporating patient views during EMA’s evaluation of benefit-risk of medicines (Juan Garcà­a Burgos, Concepcià³n Prieto Yerro)

Presentation - Workshop on patient's voice in the evaluation of medicines -European Register for Multiple Sclerosis: Pooling European data to better understand and fight multiple sclerosis (Christoph Thalheim)